IRIS
PICARDI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 14.228
NA - Nord America 4.028
EU - Europa 1.903
SA - Sud America 628
AF - Africa 100
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 2
Totale 20.918
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 10.976
US - Stati Uniti d'America 3.853
CN - Cina 1.523
HK - Hong Kong 949
IT - Italia 825
BR - Brasile 447
VN - Vietnam 305
GB - Regno Unito 273
FR - Francia 259
DE - Germania 169
IN - India 116
CA - Canada 76
AR - Argentina 70
MX - Messico 69
FI - Finlandia 60
NL - Olanda 57
ID - Indonesia 49
TR - Turchia 45
PL - Polonia 41
ES - Italia 37
ZA - Sudafrica 36
EC - Ecuador 33
UA - Ucraina 33
BD - Bangladesh 31
RU - Federazione Russa 31
AU - Australia 27
CZ - Repubblica Ceca 25
SA - Arabia Saudita 24
IQ - Iraq 22
JP - Giappone 21
PH - Filippine 21
PK - Pakistan 21
CO - Colombia 16
CL - Cile 15
MY - Malesia 15
VE - Venezuela 14
CH - Svizzera 13
SE - Svezia 12
MA - Marocco 11
PY - Paraguay 11
PE - Perù 10
UZ - Uzbekistan 10
EG - Egitto 8
AE - Emirati Arabi Uniti 7
BE - Belgio 7
BH - Bahrain 7
JO - Giordania 7
NP - Nepal 7
OM - Oman 7
SY - Repubblica araba siriana 7
TH - Thailandia 7
AT - Austria 6
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
IE - Irlanda 6
JM - Giamaica 6
LB - Libano 6
LT - Lituania 6
UY - Uruguay 6
AL - Albania 5
BO - Bolivia 5
BY - Bielorussia 5
DK - Danimarca 5
DZ - Algeria 5
KE - Kenya 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
ET - Etiopia 4
HU - Ungheria 4
IL - Israele 4
KZ - Kazakistan 4
TN - Tunisia 4
AM - Armenia 3
BG - Bulgaria 3
HN - Honduras 3
IR - Iran 3
KH - Cambogia 3
KR - Corea 3
NI - Nicaragua 3
RS - Serbia 3
CM - Camerun 2
CR - Costa Rica 2
EE - Estonia 2
GT - Guatemala 2
HT - Haiti 2
IS - Islanda 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MN - Mongolia 2
MW - Malawi 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
TL - Timor Orientale 2
XK - ???statistics.table.value.countryCode.XK??? 2
YE - Yemen 2
AF - Afghanistan, Repubblica islamica di 1
BF - Burkina Faso 1
BJ - Benin 1
Totale 20.882
Salva come PNG Salva come JPEG
Città #
San Jose 1.336
Singapore 1.040
Hong Kong 930
Ashburn 896
Rome 683
Hefei 495
Beijing 381
Boardman 265
Dallas 223
Lauterbourg 221
London 206
Shanghai 193
Ho Chi Minh City 117
Munich 87
Los Angeles 75
Council Bluffs 73
San Francisco 61
Santa Clara 59
Hanoi 55
São Paulo 52
Mexico City 48
West Jordan 41
Toronto 40
Seattle 39
Turku 38
Warsaw 37
New York 34
Amsterdam 33
Pune 32
Washington 32
Brno 22
Chennai 22
Helsinki 22
Montreal 21
Orem 21
Rio de Janeiro 21
Sona 20
Brooklyn 19
Guangzhou 19
Manchester 18
Boston 17
Johannesburg 17
Tokyo 17
Frankfurt am Main 16
Haiphong 16
Atlanta 14
Paris 14
Riyadh 13
Brasília 12
Da Nang 12
Guayaquil 12
Central 11
Lahore 11
Melbourne 11
Chicago 10
Quito 10
Stockholm 10
Tashkent 10
Thái Bình 10
Canberra 9
Milan 9
Charlotte 8
Curitiba 8
Kuala Lumpur 8
New Delhi 8
Zhengzhou 8
Belo Horizonte 7
Istanbul 7
Moscow 7
Mumbai 7
Amman 6
Ankara 6
Campinas 6
Denver 6
Haikou 6
Jakarta 6
Jinan 6
Medellín 6
Muscat 6
Ninh Bình 6
Poplar 6
Redmond 6
Baghdad 5
Baku 5
Bangkok 5
Berlin 5
Buenos Aires 5
Buffalo 5
Cairo 5
Delhi 5
Dublin 5
Hangzhou 5
Hanover 5
Hải Dương 5
Krasnodar 5
Kyiv 5
Manila 5
Ribeirão Preto 5
Secaucus 5
Sydney 5
Totale 8.518
Salva come PNG Salva come JPEG
Nome #
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 246
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 243
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 239
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 227
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 227
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 225
[Protective effect of verapamil in myocardial hypertrophy due to aortic stenosis experimentally induced in the rat] 225
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 224
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 223
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 222
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 221
[Consensus interferon: a new weapon in the treatment of chronic hepatitis C] 220
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 220
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 220
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 217
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 216
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 213
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 213
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 212
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 212
Hepatic Lysosomal Acid Lipase and lipophagy in the progression of NAFLD 210
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 207
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 206
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 204
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 204
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 203
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 203
Assessment of liver function by the exhaled breath-print during chronic liver disease 200
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 199
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 196
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 194
[Hepatocarcinoma: from epidemiology to gene therapy] 194
Blood glucose monitoring in the normal population: the PREDICA study 193
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 191
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis 190
ALEX (R) (artificial liver for extracorporeal xenoassistance): A new bioreactor containing a porcine autologous biomatrix as hepatocyte support. Preliminary results in an ex vivo experimental model 189
Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon 186
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 155
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 151
Anestesia e malattie non comuni 135
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 132
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 130
[A 73-year-old woman with vomiting and metabolic alkalosis] 130
Diabetes in chronic liver disease: from old concepts to new evidence 130
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 129
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 129
A challenging alfa-fetoprotein in a cirrhotic patient 126
GH-resistance in different stages of chronic liver disease 126
Effectiveness of group medical nutrition therapy in lowering HbA(1c) in type 2 diabetes 126
Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I 124
[A 61-year-old woman with abdominal pain and urination disorders] 124
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 123
Enhanced portal flow velocity and volume following Iloprost treatment 123
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 122
[A 74-year-old woman with macrocytic anemia] 122
A potential experimental model for the study of osteopenia in CCl4 liver cirrhotic rats 120
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 118
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 118
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 117
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 116
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 115
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 115
Anesthesia & uncommon diseases 114
Radiofrequency ablation of hepatic tissue: a new experimental animal model 114
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 113
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 112
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 111
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 109
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 109
Breathprinting of liver diseases 108
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 108
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 107
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 106
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 106
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 105
Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support 105
Donna di 35 anni con febbre, dispnea e dolore alla coscia sinistra [A 35-year-old woman with fever, dyspnea, and pain in the left thigh]. 103
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 103
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic Malignancies: Haploidentical vs HLA Identical Transplantation in Hematologic Malignancies 102
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 101
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 100
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 100
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 98
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 96
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 96
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 94
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass 93
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 90
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 87
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 87
Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study 84
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 80
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 76
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 73
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 73
The PREDICA study (PREdiction of diabetes from CApillary Blood Glucose) in the general population 73
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 73
Treatment of symptoms of neuroglycopenia with Glucose Rapid-Spray (TM) to avoid rebound hyperglycaemia 72
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 66
Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates 65
Totale 14.602
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.678
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022394 0 2 9 0 3 3 4 5 35 10 5 318
2022/2023118 21 1 3 5 5 5 15 4 3 8 45 3
2023/2024824 51 54 25 78 77 333 3 37 13 76 28 49
2024/202512.233 146 74 306 50 192 279 163 39 646 801 4.413 5.124
2025/20267.422 773 390 548 874 357 477 2.246 517 652 588 0 0
Totale 20.991